semaglutide patent expiry india Why Delhi HC rejected suit | Explained News Mounjaro leads India obesity drug

Oxidative Stress and Antioxidant Status in High-Risk Prostate Cancer Subjects

Trial population and generalizability Did the trial include people with typical comorbidities, such as high blood pressure or type 2 diabetes

Key Points: Tirzepatide (Zepbound, Mounjaro) causes diarrhea primarily because its GLP-1 component alters how food moves through your entire digestive tract

market share in GLP-1s on the strength of its strong brand and marketing prowess, with campaigns like Oh, Oh, Oh, Ozempic! resonating widely, has fallen dramatically as competition became intensified

These medications have established Novo as the dominant player, especially considering its broad indications for both type 2 diabetes and obesity